...
首页> 外文期刊>Oncology: International Journal of Cancer Research and Treatment >Modulation of multidrug resistance by cepharanthine in fresh human gastrointestinal tumor cells.
【24h】

Modulation of multidrug resistance by cepharanthine in fresh human gastrointestinal tumor cells.

机译:头孢兰氨酸在新鲜人胃肠道肿瘤细胞中对多药耐药性的调节。

获取原文
获取原文并翻译 | 示例
           

摘要

Resistance to doxorubicin (DOX) is mainly due to the effect of P-glycoprotein encoded by the multidrug resistance (MDR) gene. Cepharanthine (CEP) has been shown to circumvent multidrug resistance in P-glycoprotein-expressing cell lines. In the present study, we investigated the augmentation of DOX sensitivity by CEP using an MTT assay, and assessed the correlation between DOX sensitivity and P-glycoprotein expression by flow cytometry, in highly purified fresh human tumor cells obtained from 73 cancer patients. DOX sensitivity was decreased in proportion to P-glycoprotein expression. The cytotoxicity of DOX was increased by CEP in tumor cells possessing low DOX sensitivity. Moreover, there was a significant correlation between the effect of CEP on cytotoxicity and P-glycoprotein expression. Thus, CEP might be able to circumvent DOX resistance in cancer patients.
机译:对阿霉素(DOX)的耐药性主要归因于由多药耐药性(MDR)基因编码的P糖蛋白的作用。头孢胺素(CEP)已被证明可在表达P-糖蛋白的细胞系中规避多药耐药性。在本研究中,我们研究了使用MTT测定法通过CEP提高DOX敏感性,并通过流式细胞术评估了从73名癌症患者获得的高度纯化的新鲜人肿瘤细胞中DOX敏感性与P-糖蛋白表达之间的相关性。 DOX敏感性与P-糖蛋白表达成比例下降。 CEP在具有低DOX敏感性的肿瘤细胞中增加了DOX的细胞毒性。此外,CEP对细胞毒性的影响与P-糖蛋白表达之间存在显着相关性。因此,CEP可能能够规避癌症患者的DOX耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号